Precursor compounds for providing retinoids of the vitamin a5 pathway and uses thereof

Patent number:

WO2018091937

Galicia.svg
No items found.

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13,14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE VIGO, DE STRASBOURG UNIV
Other entities:
University of Debrecen; Universite de Strasbourg; Debreceni Egyetem
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The invention relates to the field of retinoid X receptor (RXR) signalling and a novel vitamin A pathway called Vitamin A5 pathway. Compounds which are useful to provide (R) 9-cis-13, 14-dihydro-retinoic acid an endogenous RXR ligand are claimed as well as their uses and method for preparation thereof. The compounds of the invention are useful for pharmaceutical and nutritional uses.

Comments

Other related patents

Health

METHOD FOR THE DIAGNOSIS OF A CORONAVIRUS INFECTION

Countries
Spain
Know more
Food & Agro
Health

DEVICE AND METHOD FOR MAGNETIC IN-TUBE SOLID-PHASE MICROEXTRACTION

Countries
Spain
Know more
Health
Other

SYSTEM TO DETERMINE AN EMOTIONAL STATE OF A USER (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries
Spain
Know more
Get back to patents directory